Circadian Rhythmicity {#S1}
=====================

Circadian rhythms were first observed in 1729 by Jean-Jacques d'Ortous de Mairan, who noticed that the leaves of the Mimosa plant moved with a periodicity of 24 h, even in the absence of light, thus suggesting the presence of an internal clock. It is now recognized that circadian rhythmicity integrates a mechanism for the timely coordination of cellular and broader physiological functions ([@B154]).

The Circadian Clock {#S1.SS1}
-------------------

The term circadian is used to refer to biological cycles with a time length of about 24 h ([@B163]), and the suprachiasmatic nucleus (SCN) is the "master clock" that coordinates and synchronizes those daily biological rhythms ([@B63]).

Circadian rhythmicity is also regulated by a set of peripheral "clock proteins," which form a hierarchy of oscillators that function at the cellular, tissue, and systems levels and are composed of at least three feedback loops ([@B110]; [@B37]). One loop depends on the heterodimerization of the transcription factors brain and muscle aryl hydrocarbon receptor nuclear translocator-like 1 (BMAL1) and circadian locomotor output cycles kaput (CLOCK) that, upon binding to E-box elements, induce the expression of their own repressors, named Period (PER) and Cryptochrome (CRY) proteins. Since these proteins (PER-1, -2, and -3, and CRY-1 and -2) are gradually degraded, the expression on BMAL1 and CLOCK ceases, starting a new circadian cycle.

A second loop is formed by the nuclear retinoic acid receptor-related orphan receptor (ROR) (α, β, γ) and REV-ERB (α, β), which, upon activation by the BMAL1/CLOCK heterodimer and translocation into the nucleus, bind to receptor-related orphan receptor response elements (ROREs) in the promoter of BMAL1, regulating the expression of BMAL1 ([@B110]; [@B37]).

A third loop is formed by the transcriptional activator albumin D-box binding protein (DBP) and the repressor nuclear factor interleukin 3 (NFIL3), which synergistically regulate the expression of D-box genes, including the Per genes. The interplay between these three regulatory loops is at the core of circadian rhythmicity and clock-related gene expression ([@B110]; [@B37]; [Figure 1](#F1){ref-type="fig"}).

![Mitochondria regulate circadian rhythmicity through NAD^+^ production, SIRT1 and SIRT3 activation, and mitochondrial dynamics. The Sirtuin 1 (SIRT1) and Sirtuin 3 (SIRT3) activity as HDACs is dependent on NAD^+^, and SIRT1 and SIRT3 counteract CLOCK; NAD^+^ synthesis is dependent on circadian rhythmicity, and this is related to mitochondrial dynamics. NAD^+^, Nicotinamide adenin dinucleotide (oxidized); SIRT1, Sirtuin 1; SIRT3, Sirtuin 3; BMAL1, Brain and muscle aryl hydrocarbon receptor nuclear translocator-like 1; CLOCK, circadian locomotor output cycles kaput; RORα, Retinoic acid receptor-related orphan receptor α; REV-ERBα, Reverse strand of ERBA (REV-ERBα is encoded by the opposite DNA strand of the ERBA oncogene, hence its name); NFIL3, nuclear factor interleukin 3; DBP, D-box binding protein; CRY, Cryptochrome; PER, Period; CCG, Clock-Controlled Genes.](fcell-08-00051-g001){#F1}

Circadian Rhythmicity and Its Physiological Role {#S1.SS2}
------------------------------------------------

Circadian rhythms modulate nearly every mammalian physiological process, including sleep, feeding times, energy metabolism, endocrine, and immune functions. Genome-wide transcriptional profiling analyses have shown that up to 35--50% of the genome displays rhythmic expression in eukaryotes ([@B170]). Light acts as a circadian cycle activator that helps to regulate the peaks of physiological functions such as rest-activity, respiration, blood pressure, and body temperature ([@B200]).

Circadian rhythms also regulate metabolism, and so there is a differential circadian-based expression of glucose transporters, glucagon receptors, and glycolysis-related enzymes and levels of insulin, glucagon, leptine, and cortisone ([@B133]), as well as circadian-based differences in the absorption, transport, and serum levels of cholesterol, triglycerides, and apolipoproteins ([@B143]).

Several immune functions are under direct control of the circadian clock, such as leukocyte traffic ([@B58]; [@B45]), the production of cytokines, granzymes, and perforins ([@B96]), phagocytosis and bactericidal activities ([@B25]; [@B128]), expression of diverse pattern recognition receptors (PRRs) ([@B172]), response to pathogens ([@B81]; [@B203]), anti-inflammatory responses ([@B58]), T lymphocyte responses ([@B50]), and allergic responses ([@B131]).

In addition, intestinal bacteria display endogenous circadian rhythmicity and influence the function of the intestinal circadian clock, and the host circadian rhythmicity influences the composition of bacterial communities in the intestine ([@B7]; [@B137]; [@B68]).

Pathological Consequences of Disrupting the Circadian Rhythmicity {#S1.SS3}
-----------------------------------------------------------------

The incidence of pathologies such as depression, obesity, diabetes, infarction, cancer, and others is higher in time-shift workers, and a common risk factor is inflammation ([@B26]; [@B167]). Shift work, leading to a disruption in circadian rhythmicity, has been classified within the group 2A of probable human carcinogens ([@B177]). Long flights that result in jet lag, night work, and exposure to artificial light during the night can also disrupt circadian rhythmicity, leading to irritability, anxiety, and depressive behavior ([@B161]). In this regard, animal models of light-dark cycle-controlled changes have contributed to our understanding of how circadian rhythmicity correlates with physiological functions such as metabolism and cognitive processes ([@B52]).

In many immunological and allergic diseases, including rheumatoid arthritis, bronchial asthma, atopic eczema, and chronic urticarial irritation, the intensity of symptoms and disease severity show a circadian pattern ([@B120]; [@B179]).

Mitochondrial Regulation of Circadian Rhythmicity {#S1.SS4}
-------------------------------------------------

Mitochondria constantly undergo changes in both morphology and distribution within the cytoplasm, as fused (network forming) or fissioned (punctate) mitochondria, a process collectively referred to as mitochondrial dynamics; fused mitochondria are regarded as metabolically more active than fragmented mitochondria, as cells with a fused mitochondrial network seem to have a higher respiratory rate than cells with fragmented mitochondria ([@B192]; [@B108]). Likewise, it has been suggested that there is a correlation between circadian rhythmicity and mitochondrial function ([@B83]; [@B128]; [@B168]; [@B39]; [@B49]).

Moreover, cells with disrupted mitochondria, such as Rho 0 cells, lack a well-defined circadian rhythmicity, in part due to the lack of the characteristic robust oscillatory respiratory activity observed in cells with healthy mitochondria ([@B168]). Mechanistically, the mitochondrial fusion-fission process is dependent, amongst other proteins, on dynamin-related protein-1 (Drp1) and its phosphorylation state; phosphorylated Drp1 promotes mitochondrial fusion, and Drp1 is phosphorylated in a circadian-dependent manner, thus varying its activity according to light/dark cycles ([@B166]).

The circadian clock also rhythmically regulates the biosynthesis of NAD^+^ and, in this way, the mitochondrial capacity for energy production. Mitochondrial NAD^+^ also determines the activity of the deacetylases SIRT1 and SIRT3, which in turn control the acetylation and activity of other key metabolic enzymes. Interestingly, as an example of bi-directional communication, NAD^+^ also influences clock function ([@B12]; [@B139]; [Figure 1](#F1){ref-type="fig"}).

Metabolism {#S2}
==========

Metabolism, broadly defined as the sum of biochemical processes in living organisms that produce or consume energy, is at the core of many human diseases, and the current view is that metabolism is not just a self-regulating network but one that impacts, or is impacted by, many other cellular processes ([@B41]).

Metabolic Pathways {#S2.SS1}
------------------

Recent comprehensive reviews have described glycolysis, Krebs cycle, pentose phosphate pathway, fatty acid oxidation, fatty acid synthesis, and amino acid metabolic pathways and how these play key roles in immune cell effector functions ([@B129]; [@B57]; [@B159]), highlighting the close connection between metabolism and the immune system (immunometabolism). A detailed description of these metabolic pathways is out of the scope of this review. Rather, in order to get some insight into the relationship between metabolism and the other three biological domains here referred to, we discuss, in the next two sections, the role, beyond metabolism, of specific eukaryotic metabolites, and briefly consider the concept of the metabolome.

Beyond Metabolism: Non-canonical Biological Roles of Some Eukaryotic Metabolites {#S2.SS2}
--------------------------------------------------------------------------------

### Lactate {#S2.SS2.SSS1}

Lactate is a natural ligand for the GPR81 cell membrane receptor that also recognizes other monocarboxylates; lactate enhances cell differentiation, suppresses T-cell proliferation, reduces the cytotoxic capacity of cytotoxic T lymphocytes, stimulates gene expression, and plays an important role in the tumor microenvironment ([@B117]; [@B155]; [@B99]).

Extracellular lactate concentrations in the cerebral cortex vary during the day ([@B122]), and Bmal1, a clock gene, regulates the expression of pyruvate kinase M2 (PKM2) and hence lactate production, which is required for the expression of the immune checkpoint protein PD-L1 (programmed cell death ligand 1) in tumor cells and immune cells ([@B132]; [@B43]; [Figure 2](#F2){ref-type="fig"}).

![Glycolysis and Krebs cycle-derived metabolites, as well as microbiota-derived metabolites, exert biological functions beyond energetic and biosynthetic metabolism.](fcell-08-00051-g002){#F2}

### Citrate {#S2.SS2.SSS2}

Citrate is exported from mitochondria to the cytosol by means of the mitochondrial citrate transporter; once in the cytosol, citrate is converted to acetyl-CoA and oxalacetate by the ATP-citrate lyase, and acetyl-CoA promotes the acetylation of histones and the promoter regions of TNF-α and IL-8 genes, increasing the production of IL-1β, TNF-α, and IFNγ ([@B6]; [@B106]).

### Itaconate {#S2.SS2.SSS3}

Itaconate results from the conversion of citrate to cis-aconitate and then to itaconate by the extramitochondrial enzyme cis-aconitate decarboxylase in a "break point" of the Krebs cycle during macrophage transition to a proinflammatory state. It is one of the most highly induced metabolites in activated macrophages and acts as an antibacterial metabolite by inhibiting the bacterial enzyme isocitrate lyase ([@B151]; [@B55]; [@B89]; [@B13]; [Figure 2](#F2){ref-type="fig"}). The enzyme cis-aconitate decarboxylase is encoded by the immune-responsive gene 1 (Irg1) ([@B104]); expression of Irg1 in macrophages is required for ATP and GTP synthesis ([@B124]; [@B13]).

Itaconate functions as an endogenous succinate dehydrogenase (SDH) inhibitor, and, therefore, its production or its exogenous addition (or its derivatives) regulates succinate levels, as well as mitochondrial respiration and inflammatory cytokine production ([@B35]; [@B89]; [@B106]; [@B13]). The addition of itaconate or dimethyl itaconate to macrophages reduces the expression of pro-IL-1β, IL-6, IL-12, and iNOS ([@B89]; [@B13]), and it is also possible that itaconate modifies cysteine residues of multiple target proteins, contributing to its role as an immunomodulator, as pointed out by Hooftman and O'Neil in a recent review ([@B65]; [Figure 2](#F2){ref-type="fig"}).

### Succinate {#S2.SS2.SSS4}

Succinate is produced from succinyl CoA by succinyl-CoA synthetase and accumulates in the cytoplasm of monocyte/macrophages and dendritic cells (DCs) upon LPS stimulation ([@B142]; [@B193]). Succinate accumulation, along with the induction of the glycolytic enzyme hexokinase-1, increases the activity of the respiratory chain complex II, promotes the production of mROS, stabilizes HIF-1α, regulates the transcription of pro-IL-1β, and activates the NOD-like receptor protein 3 (NLRP3) inflammasome, increasing the production of IL-1β ([@B30]; [@B114]; [@B55]; [@B105], [@B106]; [Figure 2](#F2){ref-type="fig"}).

LPS stimulation leads to the succinylation of several enzymes such as glyceraldehyde 3-phosphate dehydrogenase (GAPDH), malate dehydrogenase (MDH), lactate dehydrogenase (LDH), and the glutamate carrier-1 ([@B182]).

A specific receptor for extracellular succinate (SUCNR1/GPR91) is present in hepatic, renal, retinal, and immune cells, and its ligation leads to the secretion of various hormones, growth factors, and cytokines ([@B4]) and regulates DCs migration into lymph nodes, as well as DCs antigen presentation ([Figure 2](#F2){ref-type="fig"}). The SUCNR1/GPR91 receptor can synergize with TLR3 and TLR7, increasing the production of pro-inflammatory cytokines ([@B158]).

Succinate is also a competitive inhibitor of multiple α-ketoglutarate (α-KG)-dependent dioxygenases, including histone demethylases and prolyl hydroxylases, thus contributing to epigenetic regulation ([@B198]; [Figure 2](#F2){ref-type="fig"}).

### Fumarate {#S2.SS2.SSS5}

Fumarate is produced by the oxidation of succinate by the SDH enzyme (respiratory complex II) ([@B27]). Fumarate and its derivatives have strong bacteriostatic and bactericidal activity ([@B55]); dimethyl fumarate (DMF), through its metabolite monomethylfumarate (MMF), is also a potent immunomodulator and antioxidant ([@B194]; [@B36]). DMF induces DCs to produce IL-10, IL-12, and IL-23, tuning-down pathogenic T lymphocytes ([@B165]).

Dimethyl fumarate inhibits maturation of DCs ([@B140]), Th1 to Th2 lymphocyte shift ([@B197]), pro-inflammatory cytokine signaling ([@B103]), nuclear translocation of NF-κB ([@B59]), and the expression of cell adhesion molecules in lymphocytes and endothelial cells ([@B157]). DMF has anti-inflammatory activity on murine astrocytes by activating the Nrf2 transcription factor, reducing oxidative stress and increasing *in vivo* neuroprotection ([@B95]); hence, its therapeutic use in patients with neurological diseases such as multiple sclerosis ([@B195]).

Fumarate accumulates in macrophages in the course of β-glucan-induced innate immune training, and, strikingly, the addition of exogenous fumarate to macrophages *in vitro* induces innate immune training concomitant to the induction of an epigenetic landscape similar to that of β-glucan-induced training ([@B5]; [Figure 2](#F2){ref-type="fig"}).

The Metabolome {#S2.SS3}
--------------

The metabolome is the repertoire of small biomolecules present in cells, tissues, and body fluids, and its composition is at the core of the health status of individuals. The development of new "metabolomic platforms" has revealed that a number of metabolites present in several biological samples, such as serum and urine, vary in concentration following a circadian rhythmicity ([@B101]; [@B40]). Among them are glycolysis-related metabolites, such as glucose, glucose-6-phosphate, bisphosphoglycerate, and lactate; tricarboxylic acid (TCA) cycle-related molecules, such as acetate, acetyl CoA, citrate, isocitrate, and malonate; amino acids and their derivatives; lipid metabolites; nucleotides; antioxidants; and coenzymes such as NAD, FAD, and coenzyme A ([@B86]).

Interestingly, the daily variation in the bacterial composition within the intestine implies a daily variation in the concentration of some bacteria-derived metabolites, and the hundreds of microbiota-derived metabolites that have been identified are regarded as components of the human metabolome ([@B13]). Thus, linking eukaryotic- and bacterial-derived metabolites with the other three biological domains is discussed here.

In attempting to convey the view that mitochondria support and integrate the communication between the four mentioned biological domains, the specific roles of mitochondria are discussed in the next sections.

Mitochondria as a Metabolic Hub {#S2.SS4}
-------------------------------

Mitochondria are at the core of metabolic pathways. They produce most of the energy supply for cells by means of oxidative phosphorylation coupled to the electron transport chain (ETC); complete oxidation of glucose by cells yields up to 33.45 ATP molecules from each molecule of glucose ([@B113]).

Mitochondria also participate in the synthesis of fatty acids, metabolic intermediates, amino acids, and reactive oxygen species (ROS) ([@B174]) and the maintenance of the cellular redox state and function as a signaling platform in innate immunity ([@B190]).

The bioenergetics status of mitochondria also appears to be regulated by a fission-fusion process. Mitochondrial fission is regulated by the action of Drp1, mitochondrial fission factor (Mff), mitochondrial fission protein 1 (Fis1), MiD49, and MiD50; the assembly of Drp1 proteins constricts the mitochondria, breaking apart sections of them, downregulating OXPHOS constituents ([@B29]; [@B87]).

Mitochondrial fusion is controlled by GTPases of the dynamin superfamily, such as mitofusin 1 and mitofusin 2 (Mfn1 and Mfn2) and optic atrophy 1 (Opa1), and this process increases OXPHPOS ([@B32]; [@B34]).

Mitochondria take up calcium, which enables the modulation of Ca^2+^ levels and Ca^2+^ signaling in their immediate proximity. In addition, Ca^2+^ uptake by mitochondria stimulates the TCA cycle and oxidative phosphorylation ([@B46]; [@B189]). The activity of several bioenergetics-related enzymes, such as glycerol phosphate dehydrogenase, pyruvate phosphate dehydrogenase, isocitrate dehydrogenase, oxoglutarate dehydrogenase, SDH, and NADH dehydrogenase, are regulated by calcium ([@B134]; [@B67]).

Moreover, mitochondria can be transferred from one cell to another, and, thus, injured cells can receive mitochondria from healthy cells, enhancing their cellular bioenergetics, and can even improve organ function, such as in acute lung injury and other inflammatory diseases ([@B71]). Several mechanisms may account for the intercellular transfer of mitochondria ([@B184]), including tunneling nanotubes ([@B73]), direct cytoplasmic transfer ([@B173]), extracellular vesicles ([@B173]), and micropinocytosis ([@B82]).

Intestinal Microbiota {#S3}
=====================

Humans are colonized in diverse anatomical sites by a myriad of commensal microorganisms, collectively referred to as the microbiota (the microbial taxa associated with humans) or as the microbiome (the catalog of these microbes and their genes), an important component of which is the intestinal microbiota, which has profound effects on the host physiology ([@B186]; [@B22]).

Bacterial Colonization of the Intestinal Tract {#S3.SS1}
----------------------------------------------

Around 10^13^--10^14^ bacteria, from more than one thousand different species, colonize the human intestinal tract, and different anatomical regions within the intestine harbor distinctive microbial consortia or "microbiota" ([@B175]; [@B97]).

Fetuses are in contact with microorganisms within the uterus, and distinctive microbiomes have been found in the amniotic cavity, umbilical cord, and placenta; these microorganisms are not pathogenic, belong to the Firmicutes, Tenericutes, Proteobacteria, Bacteroidetes, and Fusobacteria phyla, and are perhaps the first bacteria to colonize the fetal gastrointestinal tract ([@B162]; [@B1]).

Within the first days of life, the intestine is colonized, mainly by aerobic microorganisms, and colonization reaches its maximal density within 72 h after birth; the phylogenetic diversity of microbiota gradually increases and allows colonization by anaerobic bacteria ([@B175]; [@B97]; [@B102]; [@B53]). Three years after birth, the intestinal microbiota has developed into a "mature" stage, characterized by its stability ([@B97]; [@B102]).

Newborns are exposed to another variety of microorganisms at the time of delivery; the vaginal route of delivery is associated with bacteria from Actinobacteria, Bacteroidetes, and Firmicutes phyla colonizing the newborn intestine ([@B84]), whereas, in infants born by the cesarean procedure, the intestine is colonized by *Staphylococcus* spp. and *Streptococcus* from the mother's skin ([@B44]).

Infants fed exclusively on maternal milk exhibit higher amounts of aerobic bacteria from the Bifidobacterium and Lactobacillus genera and a lower amount of strict anaerobic bacteria, such as *Clostridium difficile*, or facultative anaerobic bacteria, such as *Escherichia coli* ([@B84]), whereas infants fed exclusively on formula are colonized by *C. difficile*, *Bacteroides*, and *Veillonella* species ([@B188]).

Biological Role of Intestinal Microbiota {#S3.SS2}
----------------------------------------

The commensal intestinal microbiota is a key determinant for human health; it contributes to host digestive processes ([@B97]) and is a source of folate and vitamins A and B, which regulate host chromatin-modulating enzymes ([@B146]), and several amino acids, including glycine, which is required for the synthesis of glutathione, the main intracellular antioxidant and detoxifying molecule ([@B13]). It also stimulates intestinal immune responses by contributing to the development of gut-associated lymphoid tissues (GALT), especially at early stages of life, produces short-chain fatty acids (SCFAs), such as butyrate, acetate, and propionate, that have immunomodulatory properties, and regulates local immune responses ([Figure 3](#F3){ref-type="fig"}). The intestinal microbiota also suppresses pathogens through the production of bactericidal proteins and prevents the intestine from colonization by pathogenic bacteria ([@B8]; [@B97]; [@B77]; [@B75]; [@B149]).

![Intestinal microbiota-derived short-chain fatty acids, methane, and hydrogen sulfide regulate inflammatory responses. Microbiota-derived products such as SFCAs (mainly acetate, butyrate, and propionate), CH~4~, and H~2~S can cross the intestinal epithelial cell barrier and interact with the immune system cells, activating G protein-coupled receptors or passing through cell membranes, promoting cell signaling and modulating the immune response.](fcell-08-00051-g003){#F3}

Intestinal bacteria produce large amounts of methane, hydrogen sulfide, and non-gaseous metabolites, some of which have signaling properties that turn on and off an array of host genes, as well as virulence and metabolism-related microbial genes ([@B185]; [@B13]; [@B156]; [Figure 3](#F3){ref-type="fig"}).

Dysbiosis {#S3.SS3}
---------

Change in the composition of intestinal microbiota, both commensal and pathogenic, is known as dysbiosis; this condition may affect homeostasis, leading to non-specific inflammation and disease. Dysbiosis implies an imbalance in microbial metabolite composition ([@B13]) and is mainly the result of an "unhealthy" diet, the use of antibiotics, and lifestyle factors ([@B47]), it can also be caused by emotional and physiological stress ([@B92]). Dysbiosis may result in epigenetic changes in adjacent intestinal cells, as well as in hepatocytes and adipocytes ([@B13]; [@B146]).

Rapid changes in feeding habits over the last century may have contributed to our current enterotypes and general health ([@B109]). Bowel disease, irritable bowel syndrome, obesity, diabetes, and cancer have been associated with specific bacterial dysbiosis ([@B33]; [@B13]). Infants born by Cesarean delivery or from mothers that have used antibiotics and thus harbor a particular enterotype, have a higher risk of developing asthma, type I diabetes, and celiac disease ([@B118]).

There is evidence of a time-of-day-specific intestinal microbiota taxonomic composition associated with rhythmic food intake, dietary structure, gender, and the host biological clock ([@B93]; [@B183]; [@B92]), and there is a clear role for the intestinal microbiota in the regulation of metabolism, the immune system, and circadian rhythmicity. One of the mechanisms of communication between the intestinal microbiota and the other three biological domains involves microbial metabolites.

Microbial Metabolites {#S3.SS4}
---------------------

Intestinal microbiota-derived metabolites have a major influence on host physiology, particularly SCFAs, as well as hydrogen sulfide (H~2~S) and methane (CH~4~). SCFAs are produced from larger fatty acids and from the microbial catabolism of carbohydrates; and H~2~S and CH~4~, act as messengers to colonic epithelial and immune cells, impacting their metabolism, epigenetics, and gene expression.

A higher proportion of SCFA-producing bacteria within the intestinal microbiota is associated with a reduction in the risk of developing obesity, insulin resistance, and type 2 diabetes, since these compounds, particularly butyrate, increase cellular respiration and fatty acid oxidation ([@B13]). Acetate, butyrate, and propionate are the most abundant SCFAs and represent 90--95% of the total SCFAs present in the colon, at physiological concentrations in the order of 50--100 nM ([@B150]).

Short-chain fatty acids are ligands of the free fatty acid receptor 2 (also called GPR41) and the free fatty acid receptor 3 (also called GPR43) that, upon activation in intestinal L cells, induce the release of glucagon-like peptide-1 (GLP-1), which contributes to insulin signaling in white adipocytes, reducing adiposity ([@B61]; [@B3]). Propionate is a gluconeogenic factor, whereas acetate and butyrate are lipogenic factors ([@B13]; [@B156]).

Butyrate and its structural analog, β-hydroxy-butyrate, act as histone deacetylases (HDACs) and therefore play a role in epigenetic regulation ([@B171]) and exert a protective effect on the fatty liver, oxidative stress, and mitochondrial dysfunction associated with obesity and insulin resistance ([@B112]).

Butyrate downregulates the expression of co-stimulatory molecules, the maturation, metabolic reprograming, and secretion of IL-12, IL-6, and NO in monocytes/macrophages and DCs, inhibits the nuclear translocation of NF-κB, and drives T cells to produce IL-10 and IL-17; propionate inhibits the secretion of IL-12 and IL-33 by LPS-activated DCs, reduces the expression of co-stimulatory molecules on DCs, and inhibits cytotoxic T lymphocytes ([@B16]; [@B31]; [@B76]; [@B121]). Oral administration of sodium butyrate increases the percentage of CD4^+^ Foxp3^+^ Tregs in the colon but not in lymph nodes and spleen, and this correlates with the increase in IL-10 in the intestine ([@B80]; [Figure 3](#F3){ref-type="fig"}).

Hydrogen sulfide and methane help to modulate the circulatory, nervous, and immune systems, as well as endothelial cells ([@B18]). The plasma concentration of H~2~S is lower than 1 μM ([@B169]), and the mechanism proposed for its biological activity is protein modification by S-sulfhydration of cysteine residues. H~2~S has a dual activity, acting both as an anti-inflammatory and as a pro-inflammatory molecule that regulates T and B lymphocytes, NK cells, basophils, and monocytes ([@B180]; [@B19]). H~2~S reacts with heme protein groups, acting as a competitive inhibitor of mitochondrial complex IV ([Figure 3](#F3){ref-type="fig"}). However, at low concentrations, this gas increases cellular respiration ([@B107]; [@B126]).

In macrophages, the exposure to CH~4~ (as CH~4~-rich saline, 0.99 mmol/L) leads to the activation of GSK-3β, which attenuates the phosphorylation of NF-κB and MAPK, negatively regulating the production of pro-inflammatory cytokines both *in vitro* and *in vivo* ([@B201]; [Figure 3](#F3){ref-type="fig"}). As mentioned in section "Metabolome," these microbial metabolites (acetate, butyrate, propionate, hydrogen sulfide, and methane), among many others, are components of the human metabolome.

Mitochondria and Bacteria {#S3.SS5}
-------------------------

Mitochondria have a bacterial origin, and thus it is likely that bacterial products may directly interact with mitochondria, modifying their function.

Mitochondrial metabolic stress induces mitochondrial dysfunction, which may lead to the disruption of the intestinal epithelial barrier, allowing *E. coli*, and perhaps other bacteria, to cross the epithelium ([@B123]; [@B188]). Microbial products, such as butyrate and urolithin A, enhance mitochondrial functions ([@B160]), and others, such as betaine, methionine, and homocysteine, activate signaling pathways that regulate mitochondrial dynamics in the intestinal epithelium ([@B94]). *E. coli*-secreted colanic acid is endocytosed and is capable of inducing Drp1-dependent mitochondrial fission ([@B62]), and *Pseudomonas aeruginosa* secretes N-(3-oxo-dodecanoyl)-L-homoserine lactone (3OC12), a molecule thought to subvert immune defenses. In several cell types, such as in bronchial epithelial cells, 3OC12 is hydrolyzed by the enzyme lactonase paraoxonase 2 (PON2) present in mitochondria, yielding 3OC12 acid, which accumulates within mitochondria, causing mitochondrial and cytosolic acidification, increase in intracellular Ca^2+^ concentration and activation of stress signaling kinases ([@B66]).

Polymorphisms in the mitochondrial genes of the ND5, CYTB, and D-loop regions have been associated with variations in the composition of the intestinal microbiota ([@B100]); mutations in the ATP8 gene increase the relative abundance of Bacteroidales, Deferribacteraceae, Desulfovibrionaceae, and Helicobacteraceae, suggesting that mitochondria play a role in defining the microbiome ([@B64]).

It has also been suggested that mitochondria from intestinal cells are highly responsive to microbiotic signaling, with implications in inflammatory processes and colorectal cancer ([@B2]; [@B72]). In addition, itaconate, which is synthetized from the Krebs cycle aconitate, limits bacterial growth by inhibiting bacterial isocitrate lyase ([@B151]). Whether itaconate has a role in shaping intestinal microbiota remains to be investigated.

The Immune System {#S4}
=================

The immune system has long been regarded as a mechanism for self and non-self discrimination and, according to [@B74], this distinction is virtually always made by the innate immune system, which primes the adaptive immune system. New evidence indicates that in addition to the crosstalk between the innate and adaptive immune systems, the immune system, as a whole, communicates with other biological domains, as outlined in the next sections.

Circadian Rhythmicity and the Immune Response {#S4.SS1}
---------------------------------------------

Circadian rhythms regulate innate and adaptive immunity, influencing the outcome of infectious and immune system-related diseases ([@B164], [@B163]; [@B91]). High-throughput analysis has revealed rhythmicity in more than 8% of the macrophage transcriptome, including many important regulators for pathogen recognition and cytokine secretion ([@B79]), and migration to inflamed or infected tissues, cytolytic activity, and proliferative response to antigens seem to be circadian clock-dependent ([@B88]).

The total numbers of hematopoietic stem cells and mature leukocytes reach their peak in circulation during the night and decrease during the day ([@B164]), and the concentrations of cytokines and chemokines, such IL-6, TNF-α, and CXCL 12, also undergo daily around-the-clock fluctuations ([@B28]; [@B91]). Clock genes and micro RNAs (miRs) participate in the circadian control of immune responses ([@B37], [@B38]).

The magnitude of the immune response to infectious agents and their products, such as gram-negative bacteria-derived lipopolysaccharides, is dependent on the time of the day of exposure ([@B14]); it has been proposed that circadian rhythmicity allows anticipation of possible exposure to pathogenic agents, as well as more efficient use of the energy required to maintain the immune system ([@B164], [@B163]).

In a mouse model of multiple sclerosis (experimental autoimmune encephalomyelitis), the loss of the transcription factor BMAL1, a core component of the molecular clock, or the administration of the autoimmunity-eliciting antigen (MOG35--55 peptide) at midday rather than at midnight causes more severe immunopathology ([@B181]), all of which highlights the importance of the circadian cycle to the immune system.

Metabolic Regulation of the Immune Response {#S4.SS2}
-------------------------------------------

In 2002, a pioneering study demonstrated that, upon activation, T lymphocytes rely on a "Warburg-type" metabolism (aerobic glycolysis) and, remarkably, that immune co-stimulation is, in fact, a metabolic rewiring of the cell ([@B51]). Since then, knowledge on the metabolic requirements for the immune cell effector functions to take place, as well as the immunomodulatory roles of metabolic intermediates, has grown steadily. It is currently known that, for instance, "classically activated" macrophages (LPS plus IFN-γ), also referred to as M1 macrophages, use the Warburg-type metabolic pathway, whereas alternatively activated macrophages (IL-4), also referred to as M2 macrophages, use OXPHOS and β-oxidation to generate energy ([@B153]; [@B130]; [@B106]). The antimicrobial function of macrophages is regulated by metabolic reprogramming that includes succinate accumulation ([@B182]), mitochondrial ROS production ([@B191]), and mitochondrial respiratory-chain adaptation ([@B55]). Stimulation of B lymphocytes induces glycolysis and oxidative phosphorylation, which facilitates the production of IgG or IgA antibodies ([@B138]), and shifts in cell metabolism play a central role in T-cell quiescence, memory, and activation responses ([@B138]).

In addition, some metabolic intermediates contribute to delineating the immune response ([@B153]; [@B5]). Collectively, this field of research is now referred to as "immunometabolism" ([@B129]).

Intestinal Microbiota and the Immune Response {#S4.SS3}
---------------------------------------------

A driving force for the evolution of the immune system is perhaps the need to maintain a homeostatic host/microbiota interaction, shaping both host immunity and microbial ecology. The intestinal microbiota helps to shape the immune system, especially in the early stages of life, whereas microbiota composition may be related to susceptibility to immune system-related diseases in adulthood ([@B97]; [@B75]).

The intestinal microbiota contributes to the intestinal immune responses, partly by their metabolites, which may activate regulatory T cells or support systemic anti-viral immunity, as in the case of the microbial metabolite desaminotyrosine, which promotes the expression of interferon-stimulated genes ([@B176]: [@B138]).

The immune system may shape the intestinal microbial composition by means of sensors of the innate immune system, such as Toll-like receptors (TLRs), Nod-like receptors (NLRs), peroxisome proliferator-activated receptors (PPARs), and aryl hydrocarbon receptors (AhR), and, perhaps, by humoral immune responses ([@B199]; [@B78]).

Mitochondria and the Immune Response {#S4.SS4}
------------------------------------

In addition to their role as the "power-house" of the cell, mitochondria have an active role in the immune response. Activation of the innate immune response through the engagement of PRRs by pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) turns on signaling pathways that lead to the synthesis of pro-inflammatory cytokines, and this process involves mitochondria for inflammasome activation; the mitochondrial components mtDNA and mROS activate the NLRP3 inflammasome, promoting the maturation of IL-1β and IL-18 from their pro-IL-1β and pro-IL-18 precursors ([@B202]).

Mitofusin 2, one of the proteins that promote mitochondrial fusion, participates in the activation of the inflammasome, and elimination of Drp1, a protein that promotes mitochondrial fission, results in abnormal mitochondrial fusion, leading to increased activation of NLRP3-dependent activation of caspase 1 and IL-1β and IL-18 synthesis ([@B135]).

Upon microbe phagocytosis by macrophages, phagosomes bind to lysosomes and to mitochondria, allowing the interchange of ions, amino acids, and lipids, as well as the acidification of the phago-lysosome; mutation of cardiolipin synthase 1 (Cdr1) decreases the levels of mitochondrial cardiolipin, lysosome acidification, and mitophagy; inhibition of OXPHOS or deletion of mitochondrial function-related proteins, such as Aif, Opa1, and PINK1, impairs lysosomal activity ([@B42]).

In the course of immune responses against RNA viruses, infected cells sense virus-related genetic material in their cytoplasm by means of the RIG-I-MDA5-mitochondrial antiviral-signaling protein (MAVS), which is the major sensing pathway for RNA viruses ([@B196]; [@B116]); activation of MAVS is dependent on mitochondrial membrane potential (Δψm), and the coordination between MAVS signaling and mitochondrial fission increases the production of IFN-β ([@B85]).

Mitochondrial function is required for ROS production, autophagy, and antigen processing and presentation ([@B17]; [@B127]; [@B60]). Mitochondria accumulate at the immune synapse in T lymphocytes ([@B147]), and effector T lymphocytes are characterized by having fused mitochondria ([@B21]).

All this highlights the key role played by mitochondria in the immune response, and consequently, that alterations in mitochondrial function may result in deficient immunity.

Circadian Rhythmicity, Metabolism, Intestinal Microbiota, and the Immune System. How Do These Interrelate? {#S5}
==========================================================================================================

The functional relationship between circadian rhythmicity and metabolism is widely recognized ([@B148]), and so are the links between circadian rhythmicity and intestinal microbiota ([@B93]; [@B187]) and between circadian rhythmicity and the immune system ([@B56]; [@B98]; [@B163]). In addition, there is strong evidence of crosstalk between metabolism and the immune response ([@B54]; [@B23]) and between the intestinal microbiota and the immune response ([@B144]).

Fewer studies analyze the concurrent interaction between more than two of these biological domains, and when they do, they generally only include three, such as the crosstalk between the immune system, metabolism, and circadian rhythmicity ([@B48]; [@B24]) or between intestinal microbiota, circadian rhythmicity, and metabolism ([@B136]).

Based on the extensive literature on each of the individual biological domains referred to above as well as on their interactions, here we try to convey the view that the circadian clock, metabolism (both at the systemic and at the cellular level), intestinal microbiota, and immune system concurrently communicate with each other.

Moreover, based on recent findings on basic mitochondrial biology, as well as on the role of mitochondria in each of the four biological domains here mentioned, we propose that mitochondria regulate the back and forward traffic of information from one domain to the other.

Network theory has provided evidence that "a disease is rarely a consequence of an abnormality in a single gene, but reflects the perturbations of the complex intracellular network," hence the concept of network medicine ([@B11]). Perhaps, we should add that not only is a single gene not responsible for a given disease, but rather, not even only a single biological domain (circadian rhythmicity, etc.) is responsible, as different biological domains are tightly interdependent. Therefore, identifying a "hub" within the circadian clock-metabolism-intestinal microbiota-immune system network would help to understand its inner interactions better; we propose that mitochondria are such a "hub."

Mitochondria are central to energy homeostasis in eukaryotes and display a number of other functions that put them at the crossroads of multiple physiological functions. Of note, mitochondria produce signaling molecules and also receive and process signals from outside the mitochondria; hence, their proposed role as an "integrative center" ([Figure 4](#F4){ref-type="fig"}).

![Mitochondria as an integrative hub coordinating circadian rhythms, metabolism, the microbiome, and immunity.](fcell-08-00051-g004){#F4}

Mitochondrial signals, including mROS, oxidized mtDNA, extracellular ATP, and mitochondrial membrane potential (ΔΨm) depolarization, all of which are hallmarks of dysfunctional mitochondria, activate the NLRP3 (nucleotide-binding domain and leucine-rich repeat pyrin 3 domain) inflammasome ([@B145]; [@B72]). In addition, in inflammatory pathologies such as inflammatory bowel disease (IBD), mitochondrial DNA can be released into the serum and be recognized as a DAMP, contributing to a more systemic inflammatory process ([@B20]). IL-10 deficiency in IBD patients and in mouse models of colitis leads to the accumulation of damaged mitochondria and, as a result, to the activation of the NLRP3 inflammasome in macrophages ([@B70]).

The Parkinson's disease-associated mitochondrial serine protease HtrA2 downregulates the activity of NLRP3 and absent in melanoma 2 (AIM2) inflammasomes by preventing the sustained accumulation of the inflammasome adaptor apoptosis-related speck-like protein containing a CARD (ASC), and thus, HtrA2 acts as a mitochondrial quality control element that keeps NLRP3 and AIM2 inflammasomes tightly controlled ([@B152]), thus linking mitochondria and inflammation. Loss of HtrA2 increases the number of damaged mitochondria as well as the levels of unfolded respiratory chain subunits, indicating that HtrA2 is an important component in the maintenance of proteostasis in the mitochondrial inter-membrane space. On the other hand, the levels of HtrA2 increase in response to several stressors ([@B111]; [@B10]).

The circadian clock generates NAD^+^-dependent oscillations in the oxidative capacity of mitochondria through the rhythmic transcription of nicotinamide phosphoribosyl-transferase, ensuring oxidative rhythms compatible with the fasting-feeding cycle, and maximizing energy production and consumption, and, thus, NAD^+^ couples circadian rhythms and metabolism ([@B139]; [Figure 4](#F4){ref-type="fig"}). On the other hand, the concentration of NAD^+^ in mitochondria regulates the activity of the sirtuin deacetylase-3 (SIRT3), which in turn controls the acetylation and activity of other key metabolic enzymes. In most cases, acetylation reduces the enzymatic activity of modified mitochondrial proteins, presumably impairing mitochondrial metabolism and, by removing acetyl moieties from protein substrates, SIRT3 would restore their activity ([@B141]).

The circadian regulator CLOCK has an intrinsic acetyl-transferase activity, which enables circadian-dependent chromatin remodeling by acetylating histones and non-histone proteins; the CLOCK acetyl-transferase activity is counterbalanced by the deacetylase SIRT1, whose activity is dependent on intracellular NAD^+^ levels ([@B119]; [Figures 1](#F1){ref-type="fig"}, [4](#F4){ref-type="fig"}). Likewise, the circadian oscillation of NAD^+^ levels drives the activities of at least three sirtuins, SIRT1, SIRT3, and SIRT6, regulating glucose, cholesterol, and fatty acid metabolism, among other metabolic functions ([@B69]).

The concentrations of a wide array of mitochondria-associated metabolites, such as NAD^+^, ATP, mROS, and Krebs cycle intermediates are dependent on circadian rhythmicity; notable among them are components of the pyruvate dehydrogenase complex, which catalyzes the rate-limiting step in mitochondrial carbohydrate metabolism, and the carnitine palmitoyl-transferase 1, the rate-limiting enzyme in the transport of fatty acids into the mitochondrial matrix ([@B125]). In addition to clock-controlled concentration of mitochondrial enzymes, mitochondrial respiration is also strongly influenced by the molecular circadian clock ([@B168]) and by nutrition type ([@B125]), thus linking mitochondrial function, metabolism, and circadian rhythmicity.

Nutrition type is a key determinant of intestinal microbiota composition, and the intestinal microbiota play an important role in the anatomical development of the intestine to sustain such microbiota ([@B115]). Crypt formation in the intestine is dependent on the abundance and function of mitochondria, since mitochondrial dysfunction impairs the ability of the intestinal stem cells (ISCs), which have a large number of mitochondria, to produce ATP, altering their self-renewal and differentiation ([@B15]). Upon colonization, intestinal microbiota produce SCFAs, and these activate the peroxisome proliferator-activated receptor γ (PPARγ) co-activator isoform α (PGC1α), a master regulator of mitochondrial biogenesis and function and thus, cell stimulation with SCFAs results in glucose uptake, oxidative phosphorylation, fatty acid β-oxidation, and mitochondrial biogenesis ([@B13]; [Figure 4](#F4){ref-type="fig"}).

Intestinal microbiota-derived butyrate induces mitochondrial fusion ([@B112]) and a phase shift in the expression of the clock genes BMAL1 and Per2 ([@B90]). Methane, another intestinal microbiota product, can freely diffuse across cell membranes and thus reach mitochondria; the exogenous administration of methane in ischemia-reperfusion increases oxidative phosphorylation, which could indicate a bioactive role in mitochondria, thus linking intestinal microbiota with mitochondrial function and circadian rhythmicity ([@B178]).

Loss of mitochondrial quality control impairs autophagy, exacerbates inflammatory processes, and increases cell death rates, with multiple physiological consequences ([@B9]; [@B42]).

Altogether, any tentative answer to the question raised in the previous heading, "How do these interrelate?" points to mitochondria.

Concluding Remarks {#S6}
==================

We have tried to convey the view that circadian clocks, metabolism, intestinal microbiota, and the immune response tightly interact with each other and that their regulatory mechanisms seem to converge in mitochondria.

Outlining the mechanisms that regulate circadian clocks, metabolism, intestinal microbiota, and immune response communication may help to understand health-disease processes better, and, on the other hand, defining how mitochondria receive, process, and respond to signals from each one of these four biological domains, as well as the chemical nature of those signals, will improve our understanding of mitochondria.
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